Search results
Results from the WOW.Com Content Network
The new guidance brings a unified approach to addressing risks from a range of common respiratory viral illnesses, such as COVID-19, flu, and RSV, which can cause significant health impacts and strain on hospitals and health care workers.
CNN — People who test positive for Covid-19 no longer need to routinely stay away from others for at least five days, according to new guidelines from the US Centers for Disease Control and...
As of March 2024, the Centers for Disease Control and Prevention no longer advises a five-day isolation period when you test positive for COVID-19, but recommends taking other precautions once...
CDC recommends the updated 2024-2025 COVID-19 vaccine for everyone 6 months and older. This includes people who have received a COVID-19 vaccine before and people who have had COVID-19. It is especially important for the following groups to get the 2024–2025 COVID-19 vaccine: People ages 65 years and older.
It is especially important to get your 2024–2025 COVID-19 vaccine if you are ages 65 and older, are at high risk for severe COVID-19, or have never received a COVID-19 vaccine. Vaccine protection decreases over time, so it is important to stay up to date with your COVID-19 vaccine.
CDC recommends everyone ages 6 months and older receive an updated 2024-2025 COVID-19 vaccine to protect against the potentially serious outcomes of COVID-19 this fall and winter whether or not they have ever previously been vaccinated with a COVID-19 vaccine.
See infection prevention and control (IPC) guidance and practices for healthcare personnel when caring for patients, with or without COVID-19.
This updated Guidance includes strategies to protect people at highest risk of getting seriously ill and provides actionable recommendations for people with common viral respiratory illnesses, including COVID-19, flu, and RSV. Summary. What CDC knows. As the 2023-2024 fall and winter virus season ends, it's clear that the situation surrounding ...
For the first time since 2021, the Centers for Disease Control and Prevention has updated its COVID isolation guidance. Specifically, it has shifted the recommendation that someone who tests positive for COVID isolate for five days to a timeline based on the progression of the person’s symptoms.
The 2024–2025 formulations for COVID-19 vaccines approved or authorized in the United States have been updated to a monovalent vaccine based on the Omicron JN.1-lineage of SARS-CoV-2, as follows: Moderna and Pfizer-BioNTech: KP.2 strain. Novavax: JN.1 strain.